Bio-Rad Laboratories (BIO-B) Finished Goods (2009 - 2022)

Bio-Rad Laboratories (BIO-B) has 14 years of Finished Goods data on file, last reported at $309.9 million in Q2 2022.

• Finished Goods for Q2 2022 came in at $309.9 million, down 6.18% year-over-year; the trailing twelve-month figure through Jun 2022 was $309.9 million (down 6.18% YoY), and the FY2021 annual result was $312.6 million, down 8.97% from the prior year.
• Finished Goods advanced to $309.9 million in Q2 2022 per BIO-B's latest filing, from $306.0 million in the prior quarter.
• Over five years, Finished Goods peaked at $354.1 million in Q1 2018 and troughed at $298.3 million in Q4 2019.
• A 5-year average of $327.5 million and a median of $331.6 million in 2018 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2019 and 2020: Finished Goods declined 9.81% in 2019, then rose 15.12% in 2020.
• A 5-year view of Finished Goods shows it stood at $330.8 million in 2018, then dropped by 9.81% to $298.3 million in 2019, then gained by 15.12% to $343.4 million in 2020, then dropped by 8.97% to $312.6 million in 2021, then fell by 0.88% to $309.9 million in 2022.
• Business Quant data shows BIO-B's Finished Goods at $309.9 million in Q2 2022, $306.0 million in Q1 2022, and $312.6 million in Q4 2021.